Skip to content

Thiothixene

Navane (thiothixene) is a small molecule pharmaceutical. Thiothixene was first approved as Navane on 1982-01-01. It is used to treat psychotic disorders, schizophrenia, and schizophrenia spectrum and other psychotic disorders in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 2A. In addition, it is known to target histamine H1 receptor.
Trade Name Navane
Common Name Thiothixene
Indication psychotic disorders, schizophrenia, schizophrenia spectrum and other psychotic disorders
Drug Class Typical antipsychotic
Thiothixene
Get full access now